Position in CYTK
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$9,301,299
+$4,229,525 QoQ
Shares Held
109,183
+41.9% QoQ
Ownership
0.079%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#130
of 477 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CYTK Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Erste Asset Management GmbH holds $553,204,959 across 68 Biotechnology names. CYTK ranks #18 (1.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AGIO |
Agios Pharmaceuticals, Inc.
|
2,154,900 | $79,968,339 | |
| 2 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
110,210 | $59,177,259 | |
| 3 | SRPT |
Sarepta Therapeutics, Inc.
|
2,568,945 | $46,163,941 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
76,558 | $38,028,654 | |
| 5 | ROIV |
Roivant Sciences Ltd.
|
834,000 | $29,515,260 | |
| 6 | DNA |
Ginkgo Bioworks Holdings, Inc.
|
2,536,939 | $25,141,065 | |
| 7 | REGN |
Regeneron Pharmaceuticals, Inc.
|
38,716 | $24,140,974 | |
| 8 | MIRM |
Mirum Pharmaceuticals, Inc.
|
205,000 | $23,999,350 |
All Filings in CYTK
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,301,299 | 109,183 | Shares | Sole | 2026-07-28 | |
| 2026-03-31 | $5,071,774 | 76,950 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $4,889,403 | 76,950 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $4,229,172 | 76,950 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $2,542,428 | 76,950 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $2,429,485 | 60,450 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $2,843,568 | 60,450 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $3,191,760 | 60,450 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $3,275,181 | 60,450 | Shares | Sole | 2024-11-26 | |
| 2024-03-31 | $4,238,149 | 60,450 | Shares | Sole | 2024-11-26 | |
| 2023-12-31 | $3,126,700 | 37,450 | Shares | Sole | 2024-11-26 | |
| 2023-09-30 | $543,537 | 18,450 | Shares | Sole | 2024-11-26 | |
| 2023-06-30 | $601,839 | 18,450 | Shares | Sole | 2024-11-26 | |
| 2023-03-31 | $649,255 | 18,450 | Shares | Sole | 2024-11-26 | |
| 2022-12-31 | $845,379 | 18,450 | Shares | Sole | 2024-11-26 | |
| 2022-09-30 | $893,902 | 18,450 | Shares | Sole | 2024-11-26 | |
| 2022-06-30 | $724,900 | 18,450 | Shares | Sole | 2024-11-26 | |
| 2022-03-31 | $679,144 | 18,450 | Shares | Sole | 2024-11-25 | |
| 2021-12-31 | $1,030,108 | 22,600 | Shares | Sole | 2024-11-25 | |
| No filing history on record for this holder in this stock. | ||||||